To Cut Is to Cure: Can We Really Apply Z11 in Practice?

  title={To Cut Is to Cure: Can We Really Apply Z11 in Practice?},
  author={Monica Morrow and Armando E. Giuliano},
  journal={Annals of Surgical Oncology},
Axillary dissection has been a standard part of the local therapy of breast cancer since the popularization of the radical mastectomy by William Halstead in 1894. In 1985, 10-year outcomes from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B04 study were published and showed that in clinically node-negative women, there was no survival advantage for immediate axillary dissection compared to observation and delayed dissection if clinical nodal disease developed. In addition… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 19 extracted citations


Publications referenced by this paper.
Showing 1-10 of 14 references

Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2009
View 2 Excerpts

Similar Papers

Loading similar papers…